Clinical Trials Arena90d agoneutral
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA marketNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal95d agoneutral
FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review